Investing

Praxis Precision Medicines : PRAX

PRAX

Stock Data

$324.20

$5.37 (1.68%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Praxis Precision Medicines Inc is a biopharmaceutical company focused on developing treatments for central nervous system disorders. It works on innovative therapies targeting conditions caused by an imbalance in neuronal excitation and inhibition. Key projects include ulixacaltamide for essential tremor and Parkinson’s disease, and several other compounds aimed at treating various epilepsies and developmental disorders. Founded in 2015 and headquartered in Boston, Massachusetts, Praxis collaborates with notable institutions like Ionis Pharmaceuticals and The Florey Institute to advance its research.

All Praxis Precision Medicines Articles

2 Articles

Lee Jackson | Dec 29, 2025 at 7:52 AM EST

Here Are Monday’s Top Wall Street Analyst Research Calls: Doximity, KB Home, NVIDIA, Okta, On Holdings, Take-Two Interactive, Vail Resorts, and More

Pre-Market Stock Futures: The futures are trading lower as we begin the final trading week of 2025, albeit a holiday-shortened…

Lee Jackson | Nov 19, 2025 at 8:07 AM EST

Here Are Wednesday’s Top Wall Street Analyst Research Calls: DoorDash, Freeport-McMoRan, GitLab, Home Depot, Medtronic, Molson-Coors, and More

Pre-Market Stock Futures: Futures are trading higher this morning, as all the major indices once again closed lower on Tuesday,…